27th BioPharma Drug Discovery Nexus

Accelerating Innovation in BioPharma Drug Discovery

The BioPharma Drug Discovery Nexus is an exclusive, invitation-only forum that brings together senior discovery scientists, R&D leaders, and industry pioneers with innovative technology partners and solution providers shaping the future of drug discovery.

The conference agenda is thoughtfully curated to address critical challenges across target identification, lead optimization, translational research, and emerging discovery platforms. Attendees will gain insight into cutting-edge scientific advancements, evolving market dynamics, and proven strategies adopted by trailblazing organizations to accelerate discovery pipelines and deliver next-generation therapeutics.

A Premium, All-Inclusive Experience

Every delegate is treated as a VIP. From curated networking sessions to carefully designed experiences, the Nexus fosters both professional engagement and personal comfort, creating the ideal environment for productive dialogue and long-lasting connections.

Driving Conversations in Drug Discovery

This is not a conventional tradeshow. The Nexus is purposefully structured to bring together senior leaders in a focused setting that supports strategic discussions, peer learning, and professional exchange.

Curated One-to-One Engagements

Engage with fellow delegates through dedicated one-to-one meetings throughout the event. This flexible format allows you to explore strategic collaborations, exchange insights, and maximize every interaction.

Who Should Attend?

By Seniority Level

30%

43%

22%

Top Management (C-Suite, Presidents)

Senior Management (VPs, Heads)

Middle Management (Directors, Managers)

Others

By Geographical

37%

25%

15%

10%

Southern Europe

Western Europe

Central Europe

Northern & Eastern Europe

North America

Others

Biology
Neuroscience and Preclinical Research
Protein Engineering
Target Biochemistry
Computational Designing
In Vivo Pharmacology
Research & Product Development
Drug Discovery
Pharmacology and Pharmacokinetics
Medicinal Chemistry
Translational Research
High-Throughput Protein Expression
Biomarker Research
R&D
Manufacturing in Cell Therapy
Drug Design
Bioinformatics and AI/ML
Therapeutic Antibodies
Structural Chemistry
Molecular Design
Preclinical Development
Global Upstream and Cell Line Development
Nonclinical Development
Oncology Cell Therapy Innovation
DMPK
Nucleic Acid Drug Discovery
Cancer Biology
Toxicology
Vaccine Immunology
Modeling & Simulation
mRNA Protein Therapeutics
Small Molecule Research
Data Science, CADD
Synthetic Biology
Machine Learning
Molecular Modelling

Our Industry Leaders

Meet the Innovators Driving the Next Era of Drug Discovery

Luca Pellegrinet

Associate Director

T-Therapeutics Ltd

Zeno Albisser

Chief Executive Officer

Hemispherian

Sophia Qiqun Zeng

Associate Director, Biology

Opna Bio

Hazel Mak

Senior Research Scientist

AstraZeneca

Lawrence Tam

Vice President of Research & Development

Sania Therapeutics

Adam Robertson

Chief Scientific Officer

Hemispherian

Manel Kraiem

Chief Development Officer

Skymab Biotherapeutics

Gergely Toth

Chief Executive Officer, Chief Scientific Officer and Founder

Cantabio Pharmaceuticals, Inc.

Johan Luthman

EVP & Head R&D

Lundbeck

Dr. Martin Schwill

Head of Artificial Intelligence, Bioinformatics, Computer Aided Drug Discovery

Adularia

Paula Cerqueira

Vice President of Scientific Strategy

Sania Therapeutics

Andreas Hollenstein

Principal Scientist, Immunosafety

Roche

David Moreno Delgado

Associate Director Assay Development and Technologies

Galapagos

Emzo de los Santos

Principal Scientist (ML NBE)

UCB

Mate Ongenaert

Principal scientist II- Computational Biology

Johnson & Johnson Innovative Medicine

Kelly Zalocusky

Senior Director of Computational Biology, Neuroscience

Recursion

Bart Wuurman

CEO

Apaxen

Hugo Ceulemans

Senior Director- Drug Discovery Data Sciences

Johnson & Johnson Innovative Medicine

Bastiaan Bergman

VP of AI

BenevolentAI

Sonia Novo

Principal Scientist-in vitro ADME

UCB

6 Reasons to Attend

Cutting-Edge Drug Discovery Science

Explore the latest advances in target identification, hit-to-lead optimization, and preclinical development.

Translational & Drug Discovery Relevance

See how discoveries move from lab to therapeutic development through real-world biopharma case studies.

AI, Omics & Novel Technologies

Discover how AI/ML, genomics, proteomics, and high-throughput screening are transforming drug discovery.

Expert Insights from Discovery Leaders

Engage with top scientists, medicinal chemists, and R&D leaders driving innovation in biopharma.

Collaborative Networking for Innovation

Connect with CROs, biotech innovators, and pharma partners to accelerate discovery pipelines.

Proven Platform for Breakthrough Ideas

With 25 successful editions, the event is a trusted hub for sharing impactful drug discovery research.

What to expect at
the 2026 Edition

Small Molecules, Antibody & Protein Therapeutics
Novel Targets & Modalities
Data, AI & Computational Discovery
Translational Biology, Biomarkers & DMPK
Emerging Technologies for Drug Discovery Research

Connect with senior decision-makers, leading scientists, and innovative thinkers driving breakthroughs in drug discovery. Build meaningful collaborations that can accelerate your next therapeutic innovation.

27th Biopharma Drug Discovery Nexus, Zurich is your chance to explore the latest innovations, advance your expertise, and expand your professional network.

Cutting-edge plenaries with global drug discovery leaders
Hands-on workshops and real-world case studies
Focused networking to foster collaborations and partnerships

Showcase Your Solutions at the 27th Drug Discovery Nexus Conference

Take advantage of exclusive opportunities to showcase your scientific expertise, present breakthrough research, and highlight innovative drug discovery solutions. Lead high-level discussions with senior researchers, biotech innovators, and pharma decision-makers, positioning your organization at the forefront of drug discovery and translational science.

At the Nexus, your participation is active, not passive. Engage directly with decision-makers through presentations, panel and roundtable discussions, solution demonstrations, and targeted 1:1 meetings. This is your chance to influence the conversation, showcase your capabilities, and build meaningful partnerships that deliver real operational impact.

Schedule At a Glance

08:00 am - 09:00 am

Registration

09:00 am - 09:05 am

Welcome & Chairperson Address

09:05 am - 09:45 am

Panel Discussion

09:50 am - 10:10 am

Presentation

10:15 am - 12:10 pm

Mid-Morning Networking Session

Exhibition + Roundtable Discussion + Poster Presentation

12:15 pm - 12:35 pm

Presentation

12:35 pm - 01:05 pm

Panel Discussion

01:05 pm - 01:55 pm

Lunch Break

02:00 pm - 02:20 pm

Presentation

02:20 pm - 02:40 pm

Presentation

02:40 pm - 03:10 pm

Panel Discussion

03:10 pm - 03:40 pm

Panel Discussion

03:40 pm - 05:00 pm

Afternoon Networking Session

Exhibition + Roundtable Discussion + Poster Presentation

05:00 pm - 05:05 pm

Closing Remarks

08:00 am - 09:00 am

Registration

09:00 am - 09:05 am

Welcome & Chairperson Address

09:05 am - 09:45 am

Panel Discussion

09:50 am - 10:10 am

Presentation

10:15 am - 12:10 pm

Mid-Morning Networking Session

Exhibition + Roundtable Discussion + Poster Presentation

12:15 pm - 12:35 pm

Presentation

12:35 pm - 01:05 pm

Panel Discussion

01:05 pm - 01:55 pm

Lunch Break

02:00 pm - 02:20 pm

Presentation

02:20 pm - 02:40 pm

Presentation

02:40 pm - 03:10 pm

Panel Discussion

03:10 pm - 03:40 pm

Panel Discussion

03:40 pm - 05:00 pm

Afternoon Networking Session

Exhibition + Roundtable Discussion + Poster Presentation

05:00 pm - 05:05 pm

Closing Remarks

Testimonials

Great networking and one-on-one meetings with strong vendor connections. Comfortable seminar rooms and the diversity in topics was especially appreciated. It was nice to be a part of the conference!

Rick Ewing

VP, Head of Chemistry, Rapafusyn Research and Development

Very informative conference. I learned some interesting things and had good conversations.

Thomas Nittoli

Senior Director, Regeneron

Well-organized conference. Engaging discussions with exciting post-presentation questions and valuable networking opportunities.

Zoran Krunic

Sr. Manager Data Science, R&D, Amgen

The conference was great! I was able to connect with many colleagues from Industry and exchange insights on the current approaches and challenges.

Lital Magid

Director, DMPK Team and Project Leader, Teva Pharmaceuticals

Wonderful Conference, I highly recommend attending if you work in drug discovery —this will be well worth your time. We met with some great prospects and feel this event brings the right participants in our field of interest. Thank you for having us.

Business Development Manager

It was an energizing experience attending Drug Discovery Nexus and connecting with so many industry leaders across the preclinical to clinical drug development space.

Business Development Manager

What an inspiring experience at the 24th Drug Discovery Nexus! We connected with so many dedicated researchers, innovators, and industry leaders which made our time in New Jersey truly memorable.

Biocytogen

I had a great experience in New Jersey. I met a lot of great folks and had great discussions. I would love to participate in the 2026 event in Philadelphia!

Alison Heick Varghese

Principal Scientist, Pfizer

It was a real pleasure to hear and watch innovative ideas and major breakthroughs in our field. What a beautiful crowd, in many ways.

Nikolaos (Nik) Tezapsidis

President & CEO, Neurotez, Inc.

I found the scientific presentations and panel discussions very stimulating, and the conference format ideal for networking. I look forward to attending future conferences.

Patrick Schnider

VP Medicinal Chemistry
Rejuveron Vascular Therapeutics AG

Thank you for great networking opportunity. Very nice food, location and arrangements. Enjoyed some great discussions over analytics of Biologics with a couple of suppliers.

Prasad Walke, PhD

Head of Formulation Development
Valneva

Learned a lot from BioPharma Drug Discovery Nexus event. Everything was well organized! It was very successful.

Zhi-Gang Jiang

Senior Scientist
Sensei Biotherapeutics, Inc

Accelerating Innovation in BioPharma Drug Discovery

A Premium, All-Inclusive Experience

Driving Conversations in Drug Discovery

Curated One-to-One Engagements

Who Should Attend?

By Seniority Level

By Geographical

Our Industry Leaders

Luca Pellegrinet

Zeno Albisser

Sophia Qiqun Zeng

Hazel Mak

Lawrence Tam

Adam Robertson

Manel Kraiem

Gergely Toth

Johan Luthman

Dr. Martin Schwill

Paula Cerqueira

Andreas Hollenstein

David Moreno Delgado

Emzo de los Santos

Mate Ongenaert

Kelly Zalocusky

Bart Wuurman

Hugo Ceulemans

Bastiaan Bergman

Sonia Novo

6 Reasons to Attend

Cutting-Edge Drug Discovery Science

Translational & Drug Discovery Relevance

AI, Omics & Novel Technologies

Expert Insights from Discovery Leaders

Collaborative Networking for Innovation

Proven Platform for Breakthrough Ideas

What to expect atthe 2026 Edition

Key Themes

Who Participates

Why Attend

Our Previous Partners

Showcase Your Solutions at the 27th Drug Discovery Nexus Conference

Schedule At a Glance

0

+

0

0

+

0

+

Testimonials

Rick Ewing

Thomas Nittoli

Zoran Krunic

Lital Magid

Business Development Manager

Business Development Manager

Biocytogen

Alison Heick Varghese

Nikolaos (Nik) Tezapsidis

Patrick Schnider

Prasad Walke, PhD

Zhi-Gang Jiang

Scenes from Our Events: Where Insight Drives Collaboration

CONFERENCE REGISTRATION

What to expect at
the 2026 Edition